Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Bleeding Time

FacultyTitle
2von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions. (Lohmeier HK, Slobodianuk TL, Kanaji S, Haberichter SL, Montgomery RR, Flood VH) Blood Adv 2020 Sep 08;4(17):4065-4068       3 Citations
1In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice. (Shukla M, Sekhon UD, Betapudi V, Li W, Hickman DA, Pawlowski CL, Dyer MR, Neal MD, McCrae KR, Sen Gupta A) J Thromb Haemost 2017 Feb;15(2):375-387       64 Citations
2Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome. (Kanaji S, Fahs SA, Ware J, Montgomery RR, Shi Q) J Thromb Haemost 2014 Oct;12(10):1726-32       6 Citations
1Direct interaction of kindlin-3 with integrin αIIbβ3 in platelets is required for supporting arterial thrombosis in mice. (Xu Z, Chen X, Zhi H, Gao J, Bialkowska K, Byzova TV, Pluskota E, White GC 2nd, Liu J, Plow EF, Ma YQ) Arterioscler Thromb Vasc Biol 2014 Sep;34(9):1961-7       43 Citations
2Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. (Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR) J Thromb Haemost 2012 Aug;10(8):1646-52       119 Citations
3Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. (Fang J, Jensen ES, Boudreaux MK, Du LM, Hawkins TB, Koukouritaki SB, Cornetta K, Wilcox DA) Proc Natl Acad Sci U S A 2011 Jun 07;108(23):9583-8       52 Citations
1von Willebrand disease: a common pediatric disorder. (Montgomery RR, Kroner PA) Pediatr Ann 2001 Sep;30(9):534-40       12 Citations
1The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. (George TN, Johnson KJ, Bates JN, Segar JL) J Pediatr 1998 Apr;132(4):731-4       90 Citations
2Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. (Menache D, Aronson DL, Darr F, Montgomery RR, Gill JC, Kessler CM, Lusher JM, Phatak PD, Shapiro AD, Thompson AR, White GC 2nd) Br J Haematol 1996 Sep;94(4):740-5       62 Citations
1A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. (Rusy LM, Houck CS, Sullivan LJ, Ohlms LA, Jones DT, McGill TJ, Berde CB) Anesth Analg 1995 Feb;80(2):226-9       239 Citations
1Aspirin and the treatment of rheumatoid arthritis. (Csuka ME, McCarty DJ) Rheum Dis Clin North Am 1989 Aug;15(3):439-54       12 Citations
1Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. (Hanson SR, Pareti FI, Ruggeri ZM, Marzec UM, Kunicki TJ, Montgomery RR, Zimmerman TS, Harker LA) J Clin Invest 1988 Jan;81(1):149-58       135 Citations